Skip to main content
 
 


AGC Pharma Chemicals

Who we are

Your essential CDMO partner for Small Molecule APIs and Intermediates. We offer a complete range of services throughout the entire life cycle of API process development and manufacturing. We deliver comprehensive, agile, innovative solutions for your project, from clinical phase I to the commercial phase. Our commitment to the top pharma quality standards is reflected in all our processes.

Our vision

Is to be the first-choice CDMO in Europe.
To be the most trusted partner for our customers as a role model in this industry, we offer our Top Pharma Quality services, Supply Reliability, Agility, and Flexibility.

Our mission

Is to improve people’s lives by delivering our best quality products and services.
We are an essential part of the pharma industry and patient care.

We excel

Over 60 years as a API manufacturer.

We deliver

Over 40 years as a CDMO company.

We innovate

Over 100 years as a chemical company.

Values

AGC Pharma

Customer Orientation

We work hard to understand our clients and satisfy their needs

AGC Pharma

Challenge

We challenge ourselves to bring better results and achieve our goals

AGC Pharma

Operational Excellence

We ensure that our activities and processes are carried out with the highest standards of excellence

AGC Pharma

Team Excellence

We cooperate for common goals by creating a positive, innovative and learning working environment

AGC Pharma

Flexibility

We quickly adapt our approach to successfully overcome new situations

AGC Pharma

Innovation

We generate new approaches and implement creative solutions and different ways of achieving goals

Our History

1907
AGC founded in Japan

• AGC founded in Japan

1917
AGC started production of chemical products

• AGC started production of chemical products

1957
Land acquisition by Boehringer Ingelheim

• Land acquisition by Boehringer Ingelheim

1959
Extraction Plant Construction

• Extraction Plant Construction

1960
S1 Construction

• S1 Construction
• First batch of APIs manufactured

1967
S3 Construction

• S3 Construction

1974
S2 Construction

• S2 Construction

1997
Construction of Wastewater Treatment Plant

• Construction of Wastewater Treatment Plant

1998
Start of production 24×7

• Start of production 24×7

1999
First FDA (US) Approval

• First FDA (US) Approval

2001
Construction Development Laboratory / IPC

• Construction Development Laboratory / IPC

2003
Pilot Plant Construction

• Pilot Plant Construction

2006
Post Combustor Construction (Off-Gas Treatment Unit)

• Post Combustor Construction (Off-Gas Treatment Unit)

2009
First ISO 14001:2004

• First ISO 14001:2004

2010
First Protection Project

• First Protection Project
• First OHSAS 18001:2007
• First PMDA Inspection (Japan)

2013
Wastewater Treatment Plant Expansion

• Wastewater Treatment Plant Expansion

2019
Acquisition by AGC Group

• Acquisition by AGC Group

2020
R&D Laboratory Expansion

• R&D Laboratory Expansion
• EcoVadis First Assesment

2021
Micronization Plant Construction

• Micronization Plant Construction
• First ISO 45001:2018
• Last ISO 14001:2015
• Electronic Batch Record Implementation

2022
The first phase of the manufacturing plant expansion

• The first phase of the manufacturing plant expansion
• Launch of the Kilo Lab
• Micronization fully operational
• EcoVadis Platinum Medal

2023
Last FDA Inspection (US)

• Last FDA Inspection (US)
• Last PMDA Inspection (Japan)

2024
Last Inspection AEMPS (Spain)

• Last Inspection AEMPS (Spain)
• Pilot Plant Upgrade with HAPI

Our Locations

Explore our Europe and Japan sites to understand how our advanced facilities, labs, and integrated services support your projects. Discover more about our technologies through virtual site tours. For detailed support, contact our team.

Our Executive Leadership Team